SCHEMBL3754750

SCHEMBL3754750

CC1(C)CC(=O)c2sc(N3CCOCC3)c(-c3ccnc(-c4cccc(N5CCNCC5)c4)n3)c2C1

nearest known ligand 0.38

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
HTR1A P08908 2/20 0.38
HTR7 P34969 2/20 0.38
PIK3CD O00329 2/20 0.36
PIK3CA P42336 2/20 0.36
PIK3CB P42338 1/20 0.36
PIK3CG P48736 1/20 0.36
JMJD6 Q6NYC1 1/20 0.36
MAPK8 P45983 4/20 0.36
MAPK10 P53779 4/20 0.36
MAPK9 P45984 1/20 0.36
CAMK2D Q13557 2/20 0.36
BUB1 O43683 1/20 0.35
ACVR1 Q04771 1/20 0.35
KDM5B Q9UGL1 1/20 0.35
KCNH2 Q12809 1/20 0.35
BAZ2A Q9UIF9 1/20 0.34
MAPKAPK2 P49137 1/20 0.34
JAK2 O60674 2/20 0.34
CHEK1 O14757 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3769107 0.91 HTR7 (0.40) HTR1AHTR7PIK3CDPIK3CAPIK3CB
SCHEMBL3760317 0.88 HTR1A (0.42) HTR1AHTR7PIK3CDPIK3CAPIK3CB
SCHEMBL3765952 0.88 HTR7 (0.42) HTR1AHTR7PIK3CDPIK3CAPIK3CB
SCHEMBL3766072 0.86 PRKDC (0.39) PIK3CDPIK3CAPIK3CBPIK3CGBUB1
SCHEMBL3766006 0.86 PIK3CA (0.43) PIK3CDPIK3CAPIK3CBPIK3CGBUB1
SCHEMBL3766682 0.83 KDM1A (0.40) PIK3CDPIK3CAPIK3CBPIK3CGJMJD6
SCHEMBL3757704 0.82 PIK3CD (0.42) PIK3CDPIK3CAPIK3CBPIK3CGKDM5B
SCHEMBL3764433 0.80 MTOR (0.42) PIK3CDPIK3CAPIK3CBPIK3CGJAK2
SCHEMBL3761528 0.79 PLK4 (0.38) PIK3CDPIK3CABUB1JAK2
SCHEMBL3769278 0.79 PSMB8 (0.38) PIK3CDPIK3CAPIK3CBPIK3CGCHEK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2029570-B1 FUSED THIOPHENE DERIVATIVES AS KINASE INHIBITORS UCB PHARMA SA (BE) 2014-10-15 EP disclosed
US-8324204-B2 Fused thiophene derivatives as kinase inhibitors UCB PHARMA SA (BE) 2012-12-04 US disclosed
US-20100305066-A1 Fused Thiophene Derivatives as Kinase Inhibitors UCB PHARMA S.A. (BE) 2010-12-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100305066-A1 Fused Thiophene Derivatives as Kinase Inhibitors PIKFYVE, PI4KA, PIK3CA HTR1A 3013/4885HTR7 2294/4885PIK3CD 9/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.